Puma Biotechnology
Yahoo Finance • yesterday
September 2025's Promising Penny Stocks Revealed
As U.S. markets navigate a rebound with the Nasdaq and S&P 500 rising, investors are keeping a close eye on potential government shutdowns and economic shifts. Amid these broader market movements, penny stocks continue to capture interest... Full story
Yahoo Finance • 2 days ago
3 Promising Penny Stocks With Market Caps Over $600M
Despite a recent dip, major U.S. stock indexes remain near their all-time highs, reflecting a resilient market even as inflationary pressures persist. In this context, penny stocks—often representing smaller or newer companies—offer unique... Full story
Yahoo Finance • 7 days ago
Spotlight On Top Penny Stocks In September 2025
As of late September 2025, the U.S. stock market has experienced a downturn, with major indices such as the Dow Jones Industrial Average, S&P 500, and Nasdaq closing lower due to declines in tech stocks following comments from Federal Rese... Full story
Yahoo Finance • 11 days ago
3 Promising Penny Stocks With Market Caps Under $200M
As the Nasdaq and S&P 500 continue to reach new heights, investors are increasingly seeking opportunities in less conventional areas of the market. Penny stocks, while often viewed as a niche investment, can still present valuable opportun... Full story
Yahoo Finance • 12 days ago
3 Promising Penny Stocks With Market Caps Larger Than $20M
As major U.S. indices like the Dow Jones, S&P 500, and Nasdaq reach all-time highs driven by a surge in technology stocks, investors are exploring diverse opportunities across the market landscape. Penny stocks, often associated with small... Full story
Yahoo Finance • 13 days ago
3 Promising Penny Stocks With Market Caps Under $700M
As the Dow Jones Industrial Average gains traction while the Nasdaq and S&P 500 experience slight declines, investors are keenly watching for signals from the Federal Reserve's anticipated interest rate cut. In such a fluctuating market, i... Full story
Yahoo Finance • 15 days ago
3 Penny Stocks With Market Caps Over $30M To Consider
As the Nasdaq and S&P 500 reach record highs, investors are keenly watching the Federal Reserve's upcoming interest rate decision, which could influence market dynamics. Penny stocks may be a throwback term, but the opportunities they repr... Full story
Yahoo Finance • 15 days ago
Strata Critical Medical Leads Our Top 3 Penny Stock Picks
As the Nasdaq and S&P 500 reach record highs, investors are keenly watching the Federal Reserve's upcoming interest rate decision, which could influence market dynamics. Penny stocks, often associated with smaller or emerging companies, re... Full story
Yahoo Finance • 16 days ago
Vista Gold And 2 Other Promising Penny Stocks For Your Watchlist
As the U.S. stock market navigates a period of mixed performance, with the Nasdaq reaching record highs and other indices showing varied results, investors are keenly watching for opportunities that align with current economic trends. Penn... Full story
Yahoo Finance • last month
3 Promising Penny Stocks With Market Caps Under $600M
As the U.S. stock market reaches new heights, with major indices like the S&P 500 and Dow Jones Industrial Average closing at record levels, investors are keenly eyeing opportunities that may not be immediately obvious. Penny stocks, a ter... Full story
Yahoo Finance • 2 months ago
Validea Joel Greenblatt Strategy Daily Upgrade Report - 8/14/2025
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields. ARMANINO FOODS OF DIS... Full story
Yahoo Finance • 2 months ago
KORU Medical Systems And 2 Other Penny Stocks To Watch For Growth
As the U.S. stock market continues to reach new heights, with major indices like the S&P 500 and Nasdaq Composite hitting all-time highs, investors are increasingly optimistic about future growth prospects. In this context, penny stocks—th... Full story
Yahoo Finance • 2 months ago
Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT
Puma Biotechnology, Inc. (NASDAQ:PBYI) is one of the top most undervalued biotech stocks to buy now. In a report released on August 8, Gena Wang from Barclays maintained a Sell rating on Puma Biotechnology, Inc. (NASDAQ:PBYI) and set a pri... Full story
Yahoo Finance • 2 months ago
3 Penny Stocks With Market Caps Over $700M To Watch
As the Nasdaq closes at a record high, driven by a tech stock rally led by Apple, investors are witnessing solid weekly gains across major indexes. In such an optimistic market landscape, penny stocks remain a noteworthy area for those see... Full story
Yahoo Finance • 2 months ago
Puma anticipates $192M–$198M NERLYNX revenue for 2025 as company advances alisertib trials
Earnings Call Insights: Puma Biotechnology (PBYI) Q2 2025 MANAGEMENT VIEW * Alan H. Auerbach, CEO, reported total revenue for the second quarter of 2025 of $52.3 million, including product revenue net of $49.2 million from NERLYNX sale... Full story
Yahoo Finance • 3 months ago
Puma biotechnology CFO Nougues sells $33649 in stock
Maximo F. Nougues, Chief Financial Officer of Puma Biotechnology, INC. (NASDAQ:PBYI), sold a total of 9522 shares of common stock on July 8th and 9th, according to a new Form 4 filing with the Securities and Exchange Commission. The comp... Full story
Yahoo Finance • 3 months ago
Puma biotechnology SVP Hunt sells $27624 in stock
Douglas M. Hunt, Senior Vice President of Regulatory Affairs at Puma Biotechnology, INC. (NASDAQ:PBYI), a profitable biotech company with a market cap of $175 million and strong financial health according to InvestingPro, sold a total of 7... Full story
Yahoo Finance • 4 months ago
Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 6/5/2025
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persiste... Full story
Yahoo Finance • 2 years ago
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
LOS ANGELES, May 05, 2023--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 1, 2023, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restr... Full story
Yahoo Finance • 3 years ago
Puma Biotechnology to Present at B. Riley Securities’ 3rd Annual Oncology Conference
LOS ANGELES, January 12, 2023--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overvi... Full story
